Agenus Inc
AGEN
NASDAQ
Biotechnology
$7.32
USD
+0.32 (+4.57%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $315.14M
Volume 1.3M
Price Target
$25.00 – $25.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $25.00 and a min estimate of $25.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$25.00
Implied Upside
+241.5%
Analyst Covering
1
Consensus
Buy
Signal Quality
Consensus Freshness
100%
Most ratings are recent - from the last 3 months
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Emily Bodnar | HC Wainwright & Co. | Buy | Maintained | 4 days ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
TLSI
TriSalus Life Sciences Inc
$5.27
▼ -6.4%
VNDA
Vanda Pharmaceuticals Inc
$5.22
▲ +3.8%
CAMP
CAMP4 Therapeutics Corp
$5.44
▲ +20.9%
IMRX
Immuneering Corp
$5.06
▼ -2.7%
GALT
Galectin Therapeutics Inc
$3.44
▼ -2.5%
LYEL
Lyell Immunopharma Inc
$13.95
▲ +1.5%
IKT
Inhibikase Therapeutics Inc
$2.41
▲ 0.0%
ABEO
Abeona Therapeutics Inc
$5.99
▼ -5.7%
SABS
SAB Biotherapeutics Inc
$3.70
▼ -1.3%